Solcitinib - GSK 2586184 | GLPG 0778

Based on 13 reference(s) in Google Scholar 9 10 13

Axon 2539

CAS [1206163-45-2]

MF C22H23N5O2
MW 389.45

Solcitinib

Description

Selective JAK1 inhibitor originally developed for the treatment of systemic lupus erythematosus, psoriasis and ulcerative colitis.

Cell Signaling & Oncology Epigenetics Immunology Pain & Inflammation JAK-STAT EC 2.7.10.2 JAK

Selective JAK1 inhibitor for treatment of degenerative and inflammatory diseases

N-(5-(4-(3,3-dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide

[1206163-45-2]

Order

Size	Unit Price	Stock
5 mg	€90.00	In Stock
25 mg	€270.00	In Stock

Need more? Bulk Inquiry

Axon ID	Name	Description
1338	CP 690550	JAK3 inhibitor	€60.00
1378	AG 490	JAK2 inhibitor	€65.00
1588	TG 101348	JAK2 inhibitor	€80.00
1598	Ruxolitinib	JAK1 and JAK2 inhibitor	€65.00
1681	Momelotinib	JAK1 and JAK2 inhibitor	€80.00
1778	AZ 960	JAK2 inhibitor	€95.00
1843	JAK2 inhibitor 13	JAK2 inhibitor	€110.00
1955	Baricitinib	Inhibitor of JAK1 and JAK2	€70.00
1992	AS 1517499	Potent and selective STAT6 inhibitor	€130.00
2072	Tofacitinib citrate	Potent Janus Kinase 3 (JAK3) inhibitor	€115.00
2217	PF 956980	JAK3 inhibitor; analogue of Axon 1338 and 2072	€90.00
2219	AT 9283	Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl)	€85.00
2231	XL 019	JAK2 inhibitor	€100.00
2314	Stattic	Nonpeptidic small-molecule inhibitor of STAT3 activation, dimerization, and nuclear translocation	€50.00
2316	WP 1066	Potent JAK2 and STAT3 inhibitor and downregulator of antiapoptotic proteins	€95.00
2792	NVP-BSK805	Potent, selective and orally bioavailable JAK2 inhibitor	€125.00
2775	Cerdulatinib	Orally active dual Syk/JAK inhibitor	€85.00
3950	Peficitinib	Potent and orally bioavailable JAK inhibitor	€120.00
3997	ASN-002	Potent dual inhibitor of SYK and pan-JAK kinases	Inquire
4006	GLPG-0634	The first orally-available, selective inhibitor of JAK1	Inquire
4124	Momelotinib hydrochloride	JAK1 and JAK2 inhibitor	€120.00